31-45 of 516
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's RoundtableAI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's RoundtableMulti-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstractsTargeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
- advertisement
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Uncovering Hidden Symptoms of Uncontrolled Type 2 Asthma
Clinician's RoundtableUncovering Hidden Symptoms of Uncontrolled Type 2 Asthma
Alexandria May, PharmD, BCPS
Njira Lugogo, MD
Optimizing Biologic Strategies and Multidisciplinary Care in Severe Asthma
Clinician's RoundtableOptimizing Biologic Strategies and Multidisciplinary Care in Severe Asthma
Alexandria May, PharmD, BCPS
Brittany Duchene, MD
Flavia Hoyte, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
- advertisement
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
